Filing Flows › AIM ImmunoTech (AIM) › How it makes money
How AIM ImmunoTech (AIM) makes money
AIM ImmunoTech (AIM) made $26K of revenue in the second quarter 2026 (Q2 2026), +4% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $26K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $26K | +4% |
| Q1 2026 | $22K | +38% |
| Q4 2025 | $21K | -53% |
| Q3 2025 | $26K | -26% |
| Q2 2025 | $25K | -50% |
| Q1 2025 | $16K | -60% |
| Q4 2024 | $45K | -31% |
From AIM ImmunoTech's 10-Q filed Aug 7, 2026 (on EDGAR).
Questions
How does AIM ImmunoTech make money?
AIM ImmunoTech (AIM) made $26K of revenue in the second quarter 2026 (Q2 2026), +4% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.